Polymorphism On Codon 98 Of The Galectin-3 Gene Are Not Associated To Benign And Malignant Thyroid Tumors [o Polimorfismo No Códon 98 Do Gene De Galectina-3 Não Está Associado A Tumores Benignos E Malignos De Tiróide]

Galectin-3 is a multifunctional protein highly expressed in thyroid cancer. The galectin-3 gene (LGALS3) has several annotated candidates SNPs, however the relationship between galectin-3 SNPs and specific phenotypic variations relevant to health has not been evaluated. In this study, we investigated SNPs in the galectin-3 gene and a putative association with thyroid tumorigenesis. The presence of LGALS3 SNPs in thyroid carcinoma cell lines (NPA, TPC-1, WRO, ARO), thyroid tissues of 55 patients with multinodular goiter or papillary carcinoma diagnosis and lymphocytes of peripherical blood of 45 healthy individuals was evaluated by sequencing and SSCP. The analysis of LGALS3 coding sequence showed that the T98P site presents a great genotypic variation, since we observed both homozygous (AA or CC) and heterozygous (AC) patterns. In thyroid carcinoma cell lines, the genotype of NPA in the LGALS3 T98P site is CC, while TPC-1, WRO and ARO are AC. The genotypic frequency of T98P SNP observed in multinodular goiter (AC= 67%; AA= 23%; CC= 10%) and papillary carcinoma (AC= 68%; AA= 20%; CC= 12%) were similar to the frequency observed in the control population (AC= 60%, AA= 24%, CC=16%). In conclusion, no association between LGALS3 T98P genotype and the phenotype of the benign or malignant thyroid tumor was observed.50610751081Liu, F.T., Patterson, R.J., Wang, J.L., Intracellular functions of galectins (2002) Biochim Biophys Acta, 1572 (2-3), pp. 263-273Yoshii, T., Inohara, H., Takenaka, Y., Honjo, Y., Akahani, S., Nomura, T., Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells (2001) Int J Oncol, 18 (4), pp. 787-792Xu, X.C., el-Naggar, A.K., Lotan, R., Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications (1995) Am J Pathol, 147 (3), pp. 815-822Inohara, H., Honjo, Y., Yoshii, T., Akahani, S., Yoshida, J., Hattori, K., Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms (1999) Cancer, 85 (11), pp. 2475-2484Bartolazzi, A., Gasbarri, A., Papotti, M., Bussolati, G., Lucante, T., Khan, A., Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions (2001) Lancet, 357 (9269), pp. 1644-1650Nascimento, M.C.P.A., Bisi, H., Alves, V.A.F., Longatto-Filho, A., Kanamura, C.T., Medeiros-Neto, G., Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas (2001) Endocr Pathol, 2, pp. 275-279Saggiorato, E., Aversa, S., Deandreis, D., Arecco, F., Mussa, A., Puligheddu, B., Galectin-3: Presurgical marker of thyroid follicular epithelial cell-derived carcinomas (2004) J Endocrinol Invest, 27 (4), pp. 311-317Martins, L., Matsuo, S.E., Ebina, K.N., Kulcsar, M.A., Friguglietti, C.U., Kimura, E.T., Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors (2002) J Clin Endocrinol Metab, 87 (10), pp. 4806-4810Erichsen, H.C., Chanock, S.J., SNPs in cancer research and treatment (2004) Br J Cancer, 90 (4), pp. 747-751Kaklamani, V.G., Hou, N., Bian, Y., Reich, J., Offit, K., Michel, L.S., TGFBR1*6A and cancer risk: A meta-analysis of seven case-control studies (2003) J Clin Oncol, 21 (17), pp. 3236-3243Stephens, L.A., Powell, N.G., Grubb, J., Jeremiah, S.J., Bethel, J.A., Demidchik, E.P., Investigation of loss of heterozygosity and SNP frequencies in the RET gene in papillary thyroid carcinoma (2005) Thyroid, 15 (2), pp. 100-104Baumgartner-Parzer, S.M., Lang, R., Wagner, L., Heinze, G., Niederle, B., Kaserer, K., Polymorphisms in exon 13 and intron 14 of the RET protooncogene: Genetic modifiers of medullary thyroid carcinoma? (2005) J Clin Endocrinol Metab, 90 (11), pp. 6232-6236Granja, F., Morari, J., Morari, E.C., Correa, L.A.C., Assumpção, L.V.M., Ward, L.S., Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer (2004) Cancer Lett, 210, pp. 151-157Basolo, F., Giannini, R., Faviana, P., Fontanini, G., Patricelli Malizia, A., Ugolini, C., Thyroid papillary carcinoma: Preliminary evidence for a germ-line single nucleotide polymorphism in the Fas gene (2004) J Endocrinol, 182, pp. 479-484Matakidou, A., Hamel, N., Popat, S., Henderson, K., Kantemiroff, T., Harmer, C., Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene (2004) Carcinogenesis, 25 (3), pp. 369-373Cooper, D.N., Galectinomics: Finding themes in complexity (2002) Biochim Biophys Acta, 1572 (2-3), pp. 209-231Altschul, S.F., Madden, T.L., Schaffer, A.A., Zhang, J., Zhang, Z., Miller, W., Gapped BLAST and PSI-BLAST: A new generation of protein database search programs (1997) Nucleic Acids Res, 25 (17), pp. 3389-3402Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 199725:4876-82Guttmacher, A.E., Collins, F.S., Drazen, J.M., (2004) Genomic medicine: Articles from the New England Journal of Medicine, , Baltimore: The Johns Hopkins University PressGong, H.C., Honjo, Y., Nangia-Makker, P., Hogan, V., Mazurak, N., Bresalier, R.S., The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells (1999) Cancer Res, 59 (24), pp. 6239-624